Characterization of Bio-psychosocial Pain Profiles in the Perioperative Period

Sponsor
Defense and Veterans Center for Integrative Pain Management (Other)
Overall Status
Completed
CT.gov ID
NCT03081299
Collaborator
Pacira Pharmaceuticals, Inc (Industry)
471
1
36
13.1

Study Details

Study Description

Brief Summary

This is a prospective descriptive correlational design looking to characterize postoperative pain variables across various procedures that historically have significant levels of persistent post-surgical pain

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a two institution (Naval Medical Center San Diego and Walter Reed National Military Medical Center) prospective descriptive correlational design looking to characterize postoperative pain variables across various procedures that historically have significant levels of persistent post-surgical pain.

    A total goal of 1500 subjects (750 subjects at Walter Reed National Military Medical Center and 750 subjects at Naval Medical Center San Diego) will be queried regarding their postoperative pain experience following mastectomy, thoracic surgery, total knee arthroplasty, total hip arthroplasty, spinal fusion, and major abdominal surgery. Descriptive multidimensional tools (the Defense and Veterans Pain Rating Scale (DVPRS) and the electronic Pain Assessment Screening Tool and Outcomes Registry (PASTOR) will be used preoperatively, as an inpatient, and up to 6 months postoperatively.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    471 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Characterization of Bio-psychosocial Pain Profiles in the Perioperative Period
    Actual Study Start Date :
    May 1, 2016
    Actual Primary Completion Date :
    Nov 1, 2018
    Actual Study Completion Date :
    May 1, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Total Knee Arthroplasty

    Descriptive multidimensional tools (the Defense and Veterans Pain Rating Scale (DVPRS) and the electronic Pain Assessment Screening Tool and Outcomes Registry (PASTOR) will be used preoperatively, as an inpatient, and up to 6 months postoperatively.

    Total Hip Arthroplasty

    Descriptive multidimensional tools (the Defense and Veterans Pain Rating Scale (DVPRS) and the electronic Pain Assessment Screening Tool and Outcomes Registry (PASTOR) will be used preoperatively, as an inpatient, and up to 6 months postoperatively.

    Mastectomy

    Descriptive multidimensional tools (the Defense and Veterans Pain Rating Scale (DVPRS) and the electronic Pain Assessment Screening Tool and Outcomes Registry (PASTOR) will be used preoperatively, as an inpatient, and up to 6 months postoperatively.

    Thoracic Surgery

    Descriptive multidimensional tools (the Defense and Veterans Pain Rating Scale (DVPRS) and the electronic Pain Assessment Screening Tool and Outcomes Registry (PASTOR) will be used preoperatively, as an inpatient, and up to 6 months postoperatively.

    Major Abdominal Surgery

    Descriptive multidimensional tools (the Defense and Veterans Pain Rating Scale (DVPRS) and the electronic Pain Assessment Screening Tool and Outcomes Registry (PASTOR) will be used preoperatively, as an inpatient, and up to 6 months postoperatively.

    Spinal Fusion

    Descriptive multidimensional tools (the Defense and Veterans Pain Rating Scale (DVPRS) and the electronic Pain Assessment Screening Tool and Outcomes Registry (PASTOR) will be used preoperatively, as an inpatient, and up to 6 months postoperatively.

    Outcome Measures

    Primary Outcome Measures

    1. DVPRS [perioperatively to 6 months]

      To determine how predictive PASTOR/PROMIS measures are for moderate to severe acute postoperative pain as measured by the DVPRS within the first 48 hours postoperatively for all surgical groups and between surgical groups.

    2. PASTOR/PROMIS [perioperatively to 6 months]

      To assess any predictive/correlative capability of early postoperative PASTOR/PROMIS measures (7 days,14 days, and 1 month postoperatively) in the prediction of persistent pain at 3 and 6 months for all surgical groups and between surgical groups

    3. Pain phenotypes [perioperatively to 6 months]

      To describe various pain phenotypes via multidimensional pain measures throughout the subacute (7 days to 6 months) perioperative period. This description will focus on certain time points but also how such measures change over time (ie pain trajectories)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Be between the ages of 18 and 80 and having any of the following surgical procedures: mastectomy, thoracic surgery, total knee arthroplasty, total hip arthroplasty, spinal fusion, and major abdominal surgery.

    DEERS eligible

    Exclusion Criteria:
    • Total Hip/Total Knee arthroplasty revision Younger than 18 years old Refuse participation Cannot understand English Has cognitive deficiencies (subject unable to provide consent for the study, subject unable to complete initial post consent measures)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Walter Reed National Military Medical Center Bethesda Maryland United States 20889

    Sponsors and Collaborators

    • Defense and Veterans Center for Integrative Pain Management
    • Pacira Pharmaceuticals, Inc

    Investigators

    • Principal Investigator: Michael Kent, MD, Defense and Veterans Center for Integrative Pain Management

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Defense and Veterans Center for Integrative Pain Management
    ClinicalTrials.gov Identifier:
    NCT03081299
    Other Study ID Numbers:
    • 500094-1
    First Posted:
    Mar 16, 2017
    Last Update Posted:
    Mar 25, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 25, 2021